• 23. April 2024

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

ByNovo Nordisk A/S

Jun 13, 2017

Teile den Beitrag mit Freunden

http://www.news4press.com/News/Rubrik.asp weiter lesen

Booking.com